Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047698Phase 4Completed
Phase 4, randomised trial of Asplarg in male infertility (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Semen parameters and Serum sex hormone levels. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047698.